dr. jones on long-term outcomes with ibrutinib in cll
Published 7 years ago • 1.2K plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:14
dr. jeffrey jones on idelalisib and ibrutinib in patients with cll
-
2:16
dr. jones on the efficacy of venetoclax in relapsed/refractory cll
-
1:22
long-term outcomes and toxicities of ibrutinib in cll
-
1:47
dr. jeffrey jones on efficacy of idelalisib/ofatumumab combination in cll
-
1:13
dr. jones on the safety of venetoclax in cll
-
1:23
dr. jeffrey jones on idelalisib combinations in cll
-
1:24
dr jones discusses ibrutinib/bendamustine/rituximab combination for cll
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
25:09
cll: long-term updates on ibrutinib and idelalisib
-
1:09
dr. byrd on long-term safety data with ibrutinib in cll
-
1:05
long-term outcomes of patients with cll treated with continuous ibrutinib
-
2:55
clinical outcomes of patients with cll receiving long-term ibrutinib in the resonate-2 study
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
0:51
dr. seymour on role of ibrutinib in cll
-
4:07
management of cll progression after ibrutinib
-
1:53
dr. kahl on frontline btk inhibitor selection in cll
-
11:28
adverse events of ibrutinib in chronic lymphocytic leukemia
-
2:09
dr. sharman on the phase iii results of the genuine study in cll